IP Library Granted Patent US 10,435,413
Granted Patent B2
US 10,435,413 · App. 14/387,317 · Granted Oct 8, 2019

Cavitand compositions and methods of use thereof

Inventors: Kevin Travis Holman (McLean, VA); Christopher Kane (Arlington, VA)
Assignee: Georgetown University
C07D493/22B01D53/02B01J20/22B01J20/226B01J20/28095C01B23/0089C07C7/20C07C17/389C07C41/36C07F7/1804C10L3/10B01D2253/20B01D2253/204B01D2256/18B01D2257/11B01D2257/2062B01D2257/2064B01D2257/2066B01D2257/504B01D2257/704B01D2257/7022B01D2257/7025Y02P20/154
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,435,413
App. No.
14/387,317
Granted
Oct 8, 2019
Kind
B2
Abstract

Cavitand compositions that comprise void spaces are disclosed. The void spaces may be empty, which means that voids are free of guest molecules or atoms, or the void spaces may comprise guest molecules or atoms that are normally in their gas phase at standard temperature and pressure. These cavitands may be useful for industrial applications, such as the separation or storage of gasses. Novel cavitand compounds are also disclosed.

Claims (47)

1. A composition comprising a compound of formula (I):

and/or stereoisomers thereof; wherein

R is H, C 1 -C 6 alkyl, halo, or NO 2 ;

R 1 is H, C 1 -C 6 alkyl, Ph, (C 1 -C 6 alkyl) x Ph, (C(halo) 3 ) x Ph, or (halo) x Ph;

Y is —CH 2 —; and

x is an integer from 1-3;

wherein the composition is in a crystalline form that comprises void spaces of at least 15 Å 3 ; and

wherein the void spaces are free of other atoms and molecules.

2. The composition of claim 1 ; wherein for the compound of formula (I):

R is H, CH 3 , Br, or NO 2 ; and

R 1 is H, CH 3 , CH 2 CH 3 , i-Bu, Ph, 4-CH 3 Ph, 4-CF 3 Ph, 3,5-(CF 3 ) 2 Ph, or 3,5-F 2 Ph.

3. The composition of claim 1 ; wherein for the compound of formula (I):

R is H; and

R 1 is H, i-Bu, 4-CF 3 Ph, 3,5-(CF 3 ) 2 Ph, or 3,5-F 2 Ph.

4. The composition of claim 1 ; wherein for the compound of formula (I):

R is CH 3 ;

R 1 is CH 2 CH 3 , i-Bu, 3,5-(CF 3 ) 2 Ph.

5. The composition of claim 1 ; wherein for the compound of formula (I):

R is NO 2 ; and

R 1 is H or CH 3 .

6. The composition of claim 1 ; wherein for the compound of formula (I):

R is H, CH 3 , or Br; and

R 1 is H, CH 3 , CH 2 CH 3 , Ph, or 4-CH 3 Ph.

7. The composition of claim 1 ; wherein the compound of formula (I) is the rccc or the rctt stereoisomer; and wherein the compound of formula (I) is at least 95% stereoisomerically pure.

8. The composition of claim 1 ; wherein the compound of formula (I) is formula (Ia):

and/or stereoisomers thereof.

9. The composition of claim 1 ; wherein the compound of formula (I) is selected from the following (R, R 1 , Y):

(H, CH 3 , CH 2 ); (H, i-Bu, CH 2 ); (H, 4-CF 3 Ph, CH 2 ); (H, 3,5-F 2 Ph, CH 2 ); (CH 3 , 3,5-(CF 3 ) 2 Ph, CH 2 ); (CH 3 , CH 3 CH 2 , CH 2 ); (CH 3 , i-Bu, CH 2 ); and (NO 2 , H, CH 2 ).

10. The composition of claim 1 ; wherein the compositions comprise void spaces of 20 Å 3 to 300 Å 3 .

11. The composition of claim 1 ; wherein thermogravimetric analysis (TGA) of the composition reveals no more than 1% mass loss up to the temperature of sublimation of the composition.

12. The composition of claim 1 ;

wherein the composition is capable of forming a host-guest complex with one or more guest gas molecules within its void spaces; and

wherein the guest gas is selected from one or more C 1 hydrocarbon gasses, C 2 hydrocarbon gasses, and C 3 hydrocarbon gasses.

13. A chemical compound of formula (IIa);

and/or stereoisomers thereof; wherein

R 4 is i-Bu, 4-CF 3 Ph, 3,5-(CF 3 ) 2 Ph, or 3,5-F 2 Ph; and

Z is —CH 2 —.

14. A chemical compound of formula (IIb):

and/or stereoisomers thereof; wherein

R 4 is CH 2 CH 3 , i-Bu, or 3,5-(CF 3 ) 2 Ph; and

Z is —CH 2 —.

15. A chemical compound of formula (IIc):

and/or stereoisomers thereof; wherein

R 4 is H, C 1 -C 6 alkyl, Ph, (C 1 -C 6 alkyl) x Ph, (C(halo) 3 ) x Ph, or (halo) x Ph; and

Z is —CH 2 —;

wherein x is an integer from 1-3.

16. The compound of claim 15 ; wherein R 4 is H or CH 3 and Z is CH 2 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2021
From: HOLMAN, KEVIN TRAVIS; KANE, CHRISTOPHER
To: GEORGETOWN UNIVERSITY
Reel/Frame 055821/0834 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2019
From: HOLMAN, KEVIN TRAVIS
To: GEORGETOWN UNIVERSITY
Reel/Frame 050215/0487 →
Continuity (4)
Provisional Application 61799037 · Mar 15, 2013
Provisional Application 61765600 · Feb 15, 2013
Provisional Application 61614967 · Mar 23, 2012
Related Publication 20150044117A1 · Feb 12, 2015